KOEI CHEMICAL COMPANY,LIMITED (4367) Stock Price

Koei Chemical is primarily engaged in the manufacturing, sales, and import/export of fine chemical products. The company handles chemical products related to pharmaceuticals and agrochemicals, including intermediates and raw materials for pharmaceuticals, veterinary drugs, and agricultural chemicals. Additionally, it manufactures and sells functional chemical products such as catalysts, solvents, polymer additives, resins, IT-related chemicals, and photographic chemicals.

Furthermore, Koei Chemical manufactures and sells various synthetic resin raw materials, which are utilized across diverse industries. Through this product portfolio, the company meets a wide range of customer needs.

KGS Corporation, a non-consolidated subsidiary, is responsible for planning and operating employee training programs for Koei Chemical. This supports skill development among employees and contributes to the overall growth of the company.

Additionally, Koei Chemical leases land for its Chiba facility from its parent company, establishing the necessary infrastructure for business operations. This enables efficient production activities.

Koei Chemical aims to evolve its core technology in nitrogen-containing organic compounds by leveraging its years of experience. Through establishing new technologies, the company seeks to create basic compounds and functional products, contributing to societal development by providing high-value-added products.

The company has announced its medium-term management plan "KX2027" for fiscal years 2025 through 2027, with basic policies focused on strengthening profitability, accelerating business growth, and reinforcing management foundations. Through this plan, the company targets achieving an 8% ROIC and improving corporate value.

Koei Chemical anticipates continued orders in the pharmaceutical and agrochemical intermediate business and recovery in demand for organometallic catalyst-related products. For fiscal year 2027, the company plans sales of 24.7 billion yen and operating profit of 3.3 billion yen. The company also aims to maintain new product sales at 30% of total sales, enhancing its product portfolio.

The company expects growth in pharmaceutical intermediates by leveraging carbon-neutral related products and synergies with the Sumitomo Chemical Group. In particular, the company is expanding applications for CO2-absorbing amines and working to realize its vision toward 2030.

Koei Chemical is prioritizing improvements in employee engagement, digital innovation, and sustainability innovation to enhance corporate value. Through these efforts, the company aims to achieve sustainable growth and realize a better society.